Navigation Links


Urology in Medical Technology

Focal Cryoablation Highlighted in Urology Times Best of AUA Orlando 2008

Publication Highlights the Treatment's 'Low Rates of Morbidity' IRVINE, Calif., July 30 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO ), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiol...

Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology

SAN DIEGO, March 9 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies, Inc., today reported that positive clinical findings demonstrating faster recovery of urinary continence using localized manual cooling techniques during robotic-a...

Additional Data From Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress

Patients treated with Satraplatin Demonstrated Statistically Significant Improvement in Pain Response and PSA Response Rates BERLIN, March 22, 2007 /PRNewswire-FirstCall/ -- Pharmion Corporation and GPC Biotech AG today announced additional data from the double-blind, randomized satraplatin Phase ...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

...e bladder cancer whose cancer is specifically refractory (unresponsive) to current therapy are receiving Urocidin in an open label trial. Thirty-one urology centres in North America are participating in this trial and recruitment of 105 evaluable patients was completed in March, 2009. Data from the f...

WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center

... the New Jersey Organ and Tissue Sharing Network. In 2005, he received the National Medical Award for Excellence in Transplantation by the Kidney and urology Foundation of America, Inc. Saint Barnabas Health Care System Renal and Pancreas Transplant Division The Saint Barnabas Renal and Pancreas ...

Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)

...Newswire/ -- Spirus Medical, Inc. ( www.spirusmed.com ), a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, urology and gynecology, announced that physicians using its Endo-Ease(TM) line of devices have performed complete examinations of the small intestine, or pan-...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

....D., Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ; Co-Leader: Peter A. Jones, Ph.D., Distinguished Professor of urology and Biochemistry & Molecular Biology, University of Southern California ; "Targeting the PI3K Pathway in Women's Cancers" / Leader: L...

RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days

...2 weeks, according to data published in the June issue of The Journal of urology . RAPAFLO(TM) was developed and is manufactured by Watson Pharmaceuticals,...receptors," said Leonard S. Marks, MD, author of the study and professor of urology at the Geffen School of Medicine, the University of California at Los Ange...

Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples

...ein I, Hatzichristou DG, Krane RJ. Impotence and its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study, Journal of urology . Vol. 151, 54-61, January 1994 and World Population Projection Program Of United Nations (2002 Revision) with indirect standardization. (5) Shab...

Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis

... - Eight Studies Presented at Leading urology Meeting Show that Simple Urine Test for PCA3 Gene May Improve Accuracy of Prostate Cancer Detection, Reduce Unnecessary Biopsies - - Gen-Probe to...

Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

...s from this landmark study confirm that PROVENGE prolongs survival with a favorable benefit to risk profile," said Paul Schellhammer, MD, professor of urology at Eastern Virginia Medical School / Sentara medical group and a principal investigator of the IMPACT study. "The treatment effect on overall ...

EAU Position Statement on Screening for Prostate Cancer

... ARNHEM, The Netherlands, April 16 /PRNewswire/ -- The European Association of urology (EAU) has taken into consideration the recent scientific information on randomised screening studies on prostate cancer (Schröder et al, NEJM 2009). ...

Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)

...an important milestone and, coupled with the forthcoming launch of GELNIQUE, marks the continued strength and expansion of Watson's Brand Division and urology franchise," said Paul Bisaro, President and Chief Executive Officer of Watson . "We are confident that the proven rapid efficacy and safety of RAPAF...

PSA Screening Cuts Deaths by 20%, Says World's Largest Prostate Cancer Study

...2,000 men in seven countries, aged 55-69; only those who had not been screened could take part. The findings are being unveiled at the annual European urology Congress in Stockholm, Sweden (17 - 21 March 2009). By initially screening men 55 to 69 years with the PSA marker and offering regular follow u...

New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability

...red combination of efficacy and tolerability when utilized to treat symptoms of overactive bladder," said David R. Staskin, MD, associate professor of urology at Tufts University School of Medicine and Caritas - St. Elizabeth's Medical Center and lead author of the study. "GELNIQUE has the potential to be ...

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

...euticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate ca...

Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study

...euticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate can...

Foreign Medical Devices are in High Demand in Russia

...Prosthetic and orthopaedic appliances - Other surgical and medical instruments - Cardiovascular devices - ENT devices - Nephrology and urology devices - Neurology devices - Anesthesia and respiratory devices - Endoscopy devices - Drug delivery devices - In vitro diagnostic...

Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule

...ong physician interest and patient acceptance of PTNS therapy at the participating centers," said Dr. Kenneth M. Peters, Chairman of the Department of urology at Beaumont Hospital in Royal Oak, Michigan, and the SUmiT study's principal investigator. "We believe the study's design will deliver to the medical...

Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence

... stress urinary incontinence, now available in the January 2009 Journal of urology . This is the first, large, multicenter randomized trial comparing the safe...ique," said Gamal Ghoniem, MD, Head, section of Voiding Dysfunction, Female urology and Reconstruction and Chairman of Medical Education at Cleveland Clinic Fl...

New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life

...ic Laparoscopists (AAGL), ETHICON Women's Health & urology today announced results of a seven-country study m...who have used medication ETHICON Women's Health & urology currently is recruiting for two clinical trials to...en's Health and Urology ETHICON Women's Health & urology offers treatment solutions for a range of common, ...

Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial

...to be completed by early fall of 2009, is to take place at approximately 20 urology and urogynecology centers across the United States, with total enrollment o...d painful bladder syndrome. Dr. Peters is the Chairman of the Department of urology and Director of Clinical Research -- Department of Urology at William Beaum...

Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering

...euticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate can...

Nationwide Survey Shows Infertility Patients Prefer ENDOMETRIN(R) Compared With Other Progesterone Supplements

...offers the Q?CAP(TM), the first and only needle-free reconstitution device, for use with its fertility treatments. Ferring's line of orthopaedic and urology products includes EUFLEXXA(R) (1% sodium hyaluronate) hyaluronic acid for pain from osteoarthritis in the knee and PROSED(R)/DS for the relief of disc...

New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence

...pany. About ETHICON Women's Health and Urology ETHICON Women's Health & urology offers treatment solutions for a range of common, female pelvic health diso...ss urinary incontinence and pelvic organ prolapse. ETHICON Women's Health & urology is a division of ETHICON, Inc, a Johnson & Johnson company. For more inform...

Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000

...ceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate can...

Soyfoods Do Not Impact Sperm Count

...beverage every three days. This is not considered a high intake of any food under most circumstances. Dr. Larry Ross, Past President of the American urology Association noted that "Like most epidemiological reports, this study is retrospective and is therefore inherently subject to a variety of biases. The...

The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds

...her health issues," said Ridwan Shabsigh, M.D., director of the Division of urology at Maimonides Medical Center in Brooklyn, NY and professor of clinical urology at Columbia University. "It's important for men with ED to talk with their ...

ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer

...ial will begin for the treatment of recurrent prostate cancer in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of urology at NYU School of Medicine and medical monitor for the trials said, "I have personally reviewed the preliminary data and observed the Sonablate(R) 500 ...

Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder

...pipeline products highlight Watson's commitment to urology - Embargoed Until 2:10 PM EDT...novel treatments that continually address areas of urology with limited therapeutic options," said Edward Hei...tially important additions to the expanding Watson urology franchise." In the first trial (abstract #2037),...

Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System

...urinary frequency and urge incontinence, symptoms often associated with overactive bladder (OAB). Dr. Kenneth M. Peters, Chairman of the Department of urology at Beaumont Hospital in Royal Oak, Michigan, leads the OrBIT (OveRactive Bladder Innovative Therapy) multi-center trial and presented the comparative ...

Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting

...the focus of 17 clinical studies presented at the six-day annual meeting of the American Urological Association (AUA) in Orlando, which is the largest urology meeting of the year. Also, a total of six post-graduate educational courses and workshops related to cryoablation were sponsored by the AUA and, for...

Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association

...ceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate can...

Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study

... Principal Investigators are Ralph Clayman, MD, Chair of the Department of urology at University of California Irvine, and Margaret Pearle, MD, PhD, Professor of urology at University of Texas Southwestern. About Omeros Corporation Omeros Co...

FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer

...atment of recurrent prostate cancer with the Sonablate(R) 500 in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of urology at NYU School of Medicine and medical monitor for the trial said, "It is my pleasure to serve as the medical monitor for the prostate cancer clinical ...

Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting

...the nation. City of Hope is located in Duarte, Calif., just northeast of Los Angeles, and is ranked as one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information...

Indevus Pharmaceuticals Provides Update on PRO 2000 Program

...ceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA XR(TM) and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate can...

Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia

... and businesses. Watson is committed to providing innovative solutions in urology care. With seven products currently available to address conditions ranging...ats the symptoms associated with urological conditions, but that helps make urology patients' lives more livable. The Watson portfolio in the U.S. includes Oxy...

Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)

...ceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA XR(TM) and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate can...

ORTHO EVRA(R) Prescribing Information Updated

...ticals, Inc., is a leader in the fields of women's health and urology, celebrating more than 75 years of partnering with women. Ortho Women's Health & urology is committed to helping people live healthier lives and to meeting the needs of providers and patients with products such as ORTHO TRI-CYCLEN(R) LO (n...
Other TagsblueblueblueblueblueDinogungungun
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2A window that washes itself? 2Fish with attitude: Some like it hot 2Vitamin D May Be Tied to Heart Disease Via Genes 62564 1Vitamin D May Be Tied to Heart Disease Via Genes 62564 2Northern California Cancer Centers Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Rese 62562 1Northern California Cancer Centers Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Rese 62562 2Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 62560 1Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 62560 2
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
Other Contentsrecombinationrecombinationrecombinationrecombinationrecombinationredoxredoxredoxreductionreductionreductionreductionreductionreductionreductionreductionreductionsequencesequencesequencesequencesequencesequencesequencesequencesequencesequencerepeatedrepeatedrepeatedrepeatedrepeatedrepeatedrepeatedrepeatedrepeatedrepeatedreplicationreplicationreplicationreplicationreplicationreplicationreplicationreplicationreplicationenzymeenzymeenzymeenzymeenzymeenzymeenzymeenzymeenzyme